Dr. Jitendra N Bhatt , MD
Internal Medicine • Denton, TX
1108 Dallas Dr Ste 337
Denton, TX 762055123
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Jitendra Bhatt is listed in NPPES under Internal Medicine.
-
NPI assigned on January 11, 2007; this date does not establish years in practice.
-
Published CMS data list 359 Original Medicare Part B services in 2021.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2021. Published rows only; this is not a quality measure.
-
Published Part B service records, 2021:
- 99214 — Established patient outpatient office visit: 250 service units.
- 99213 — Established patient outpatient office visit: 109 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2021. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2020 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2021). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 28 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Eliquis (Apixaban) — 15 prescription fills, including refills.
- Sertraline Hcl — 13 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 85% of clinicians listed under Internal Medicine in Denton, TX (2024, 32 clinicians with data). Median for this group: 234. Middle half: 142 to 1,378.
Fewer Part D prescriptions than 90% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: 828. Middle half: 121 to 4,824.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,007 in 2017 to 359 in 2021.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017–2021.
Practice Location & Contact Primary Location
1108 Dallas Dr Ste 337
Denton, TX 762055123
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $40,752 in 2021
The total amount Medicare approved for these services in 2021. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2021.
Paid by Medicare
About $21,947 in 2021
The part of the Medicare-allowed amount that Medicare itself paid in 2021, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2021.
30-day fills
28 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$4,438 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2019
All general payments: $542.51 across 35 records.
By nature of payment
- Food and Beverage: $542.51 across 35 records.
Reporting-company totals (3 largest of 13)
- AstraZeneca Pharmaceuticals LP: $145.17 across 9 records.
- Novo Nordisk Inc: $62.15 across 4 records.
- Amarin Pharma Inc.: $51.56 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2019 (published June 30, 2026).
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Denton and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 85% of clinicians listed under Internal Medicine in Denton, TX (2024, 32 clinicians with data). Median for this group: 234. Middle half: 142 to 1,378.
Fewer Part D prescriptions than 90% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: 828. Middle half: 121 to 4,824.
Part D drug cost
A lower Part D drug cost than 60% of clinicians listed under Internal Medicine in Denton, TX (2024, 32 clinicians with data). Median for this group: $8,668. Middle half: $1,032 to $165,116.
A lower Part D drug cost than 70% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: $64,859. Middle half: $4,211 to $436,775.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Bhatt are from 2021.
49 active clinicians are listed under Internal Medicine with a practice address in Denton, TX (9,191 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Denton
18.4% of these 49 clinicians have the CMS telehealth indicator.
61.2% of these 49 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 88% from 3,007 in 2017 to 359 in 2021.
- 2017: 3,007
- 2018: 3,178
- 2019: 2,496
- 2020: 877
- 2021: 359
-
Medicare-allowed amount
Medicare-allowed amount decreased 82% from $230,845 in 2017 to $40,752 in 2021.
- 2017: $230,845
- 2018: $216,481
- 2019: $178,811
- 2020: $71,997
- 2021: $40,752
-
Paid by Medicare
Paid by Medicare decreased 87% from $172,091 in 2017 to $21,947 in 2021.
- 2017: $172,091
- 2018: $160,287
- 2019: $127,751
- 2020: $50,547
- 2021: $21,947
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 100% from 15,980 in 2019 to 28 in 2024.
- 2019: 15,980
- 2020: 13,842
- 2021: 7,995
- 2022: 11
- 2024: 28
-
30-day fills
30-day fills decreased 100% from 31,097 in 2019 to 28 in 2024.
- 2019: 31,097
- 2020: 29,477
- 2021: 17,951
- 2022: 33
- 2024: 28
-
Part D drug cost
Part D drug cost decreased 100% from $888,283 in 2019 to $4,438 in 2024.
- 2019: $888,283
- 2020: $854,821
- 2021: $581,876
- 2022: $175
- 2024: $4,438
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2019 only.
Sources: CMS Medicare Physician & Other Practitioners (2021), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2019), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2019 (payments made January 1 – December 31, 2019): 35 records totaling $542.51.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $21.80 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $21.09 |
| AbbVie, Inc. |
Food and Beverage
In-kind items and services
|
Synthroid | General | $20.92 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
LYRICA | General | $20.69 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $19.55 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $19.30 |
| Amarin Pharma Inc. |
Food and Beverage
In-kind items and services
|
Vascepa | General | $18.57 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $18.50 |
| Amarin Pharma Inc. |
Food and Beverage
In-kind items and services
|
Vascepa | General | $18.47 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $18.46 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xofluza | General | $18.14 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
SYMBICORT | General | $16.73 |
| AbbVie, Inc. |
Food and Beverage
In-kind items and services
|
Synthroid | General | $16.40 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $16.08 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Tresiba | General | $16.08 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
MYRBETRIQ | General | $15.81 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
XARELTO | General | $15.47 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Tresiba | General | $15.02 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Tresiba | General | $14.97 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
XARELTO | General | $14.53 |
| Amarin Pharma Inc. |
Food and Beverage
In-kind items and services
|
Vascepa | General | $14.52 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xofluza | General | $14.33 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
TOUJEO | General | $14.13 |
| AbbVie, Inc. |
Food and Beverage
In-kind items and services
|
Synthroid | General | $13.86 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BRILINTA | General | $13.67 |
(top 25 shown)
Source: CMS Open Payments, program year 2019, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2020 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2021; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
250 | 206 | $182.32 | $124.89 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
109 | 90 | $130.04 | $87.43 |
Source: CMS Part B by Provider and Service, 2021; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Eliquis | Apixaban | 15 | 210 | $4,376.25 | — |
| Sertraline Hcl | Sertraline Hcl | 13 | 180 | $61.27 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Career & Practice History
NPI enumerated January 11, 2007.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Denton
- Dr. Krishna Kumar, MD
- Dr. Kamran Chaudhry, MD
- Dr. Narayan Kc, MD
- Dr. Vijaya Kommineni, MD
- Dr. Aitazaz Shah, MD
- Dr. Kalee Moore, DO
Mailing Address
1108 Dallas Dr Ste 337
Denton, TX 762055123
Phone: 9408980232